Evidence map›Paper›PMID 37242015›Full record

ArticleNanomaterials (Basel, Switzerland)2023

UV-Nanoimprint Lithography for Predefined SERS Nanopatterns Which Are Reproducible at Low Cost and High Throughput.

Karolina Milenko, Firehun Tsige Dullo, Paul C V Thrane, Zeljko Skokic, Christopher A Dirdal

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Advanced Manufacturing on Nano- and Microscale.Nanomaterials (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karolina MilenkoSINTEF Microsystems and Nanotechnology, Gaustadalleen 23C, 0737 Oslo, Norway.
Firehun Tsige DulloSINTEF Microsystems and Nanotechnology, Gaustadalleen 23C, 0737 Oslo, Norway.ORCID 0000-0002-7446-8699
Paul C V ThraneSINTEF Microsystems and Nanotechnology, Gaustadalleen 23C, 0737 Oslo, Norway.ORCID 0000-0001-5296-2912
Zeljko SkokicSINTEF Microsystems and Nanotechnology, Gaustadalleen 23C, 0737 Oslo, Norway.
Christopher A DirdalSINTEF Microsystems and Nanotechnology, Gaustadalleen 23C, 0737 Oslo, Norway.ORCID 0000-0002-9632-3239

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A controlled and reliable nanostructured metallic substrate is a prerequisite for developing effective surface-enhanced Raman scattering (SERS) spectroscopy techniques. In this study, we present a novel SERS platform fabricated using ultra-violet nanoimprint lithography (UV-NIL) to produce large-area, ordered nanostructured arrays. By using UV-NIL imprinted patterns in resist, we were able to overcome the main limitations present in most common SERS platforms, such as nonuniformity, nonreproducibility, low throughput, and high cost. We simulated and fabricated C-shaped plasmonic nanostructures that exhibit high signal enhancement at an excitation wavelength of 785 nm. The substrates were fabricated by directly coating the imprinted resist with a thin gold layer. Avoiding the need to etch patterns in silicon significantly reduces the time and cost of fabrication and facilitates reproducibility. The functionality of the substrates for SERS detection was validated by measuring the SERS spectra of Rhodamine 6G.

Indexed as

nanopatterningRaman spectroscopysensorssurface-enhanced Raman scattering (SERS)UV-nanoimprint lithography (UV-NIL)

Identifiers

PMID37242015
PMCPMC10224034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.